Nocdurna (Desmopressin)

Desmopressin, the active ingredient in Nocdurna, is a vasopressin (antidiuretic hormone) analog presented as a sublingual tablet for sublingual use. It selectively stimulates renal V2 receptors to reduce urine output and also raises plasma factor VIII and von Willebrand factor, making it useful for treating nocturnal enuresis in children and adolescents, central diabetes insipidus, and for hemostatic control in hemophilia A and von Willebrand disease.

GNH USA supplies Nocdurna as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Desmopressin acts on the antidiuretic hormone pathway and is indicated for the following conditions:

Nocturnal enuresis: Reduces nighttime urine production, helping children and adolescents achieve dry nights. Central diabetes insipidus: Increases water reabsorption in the kidneys to control polyuria and polydipsia. Hemophilia A and von Willebrand disease (hemostatic use): Elevates plasma factor VIII and von Willebrand factor levels to improve clot formation during bleeding episodes or surgical procedures.

Desmopressin may cause a range of adverse reactions, which are grouped by frequency and severity.

Common Side Effects: - Headache: mild to moderate pain often reported during treatment. - Nausea: occasional upset stomach or feeling of queasiness. - Nasal congestion: sensation of blocked nasal passages. - Dizziness: transient light‑headedness, especially after standing.

Serious or Rare Side Effects: - Hyponatremia: severe low blood sodium that can lead to seizures or coma. - Water intoxication: excessive fluid retention causing swelling or pulmonary edema. - Thromboembolic events: rare clot formation in veins or arteries. - Allergic reactions: rash, itching, swelling, or anaphylaxis.

When prescribing Desmopressin, clinicians should consider several safety measures and monitoring requirements. - Assess fluid balance: monitor intake and output to avoid water overload. - Check serum sodium: evaluate baseline and periodic sodium levels, especially in at‑risk patients. - Caution in renal impairment: adjust use and monitor kidney function closely. - Avoid concomitant hyponatremia‑inducing drugs: limit use with diuretics or certain antidepressants. - Use with caution in pregnancy: limited data; weigh benefits against potential risks. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Desmopressin can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Concomitant use of thiazide diuretics: may increase risk of hyponatremia. - Co‑administration with carbamazepine: can reduce Desmopressin’s antidiuretic effect. - Combined therapy with other antidiuretic agents (e.g., chlorpropamide): heightens water retention risk.

Moderate Interactions (Monitor Closely): - NSAIDs (e.g., ibuprofen): may impair renal water handling, requiring sodium monitoring. - Selective serotonin reuptake inhibitors (SSRIs): potential additive effect on serum sodium. - Anticoagulants (e.g., warfarin): may enhance hemostatic response, monitor clotting parameters.